查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1136914

2022-2029 年護理點數據管理系統的全球市場

Global Point Of Care Data Management Systems Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

床旁數據管理系統的市場增長受到數據管理系統技術進步的推動，例如遠程監控、床旁數據管理系統的廣泛引入、生活方式相關疾病的發病率增加，以及醫療費用的增加。

醫療點數據管理系統對健康記錄的需求不斷增長，預計將推動市場增長

醫療記錄床旁數據管理系統的日益普及預計將在預測期內推動市場增長。根據 2020 年 11 月發表在《實用檢驗醫學》上的一篇文章，認證和監管標準凸顯了將 POC 測試結果整合到患者電子病歷中的日益增長的需求。這有助於監測和跟蹤 POCT 結果的可訪問性、能力，防止不必要的重複測試，並提供患者結果的證據。由於 POCT 結果用於臨床決策，相關參考區間、測量單位、適用的臨界值、測試日期和時間，以及儀器序列號、操作員識別號、試劑批號、質量控制（QC ) ) 記錄結果很重要，以便可以追溯到結果。此外，POCT 結果應與其他中心實驗室結果明顯區分開來，以避免來自不同分析技術的結果混淆或漂移。 POCT 現在已成為所有醫院的常規手術，並已成為其他各種醫療環境中患者護理的標準。

此外，主要參與者正在採用市場策略。例如，2020 年 3 月，西門子 Healthmeyers 和 Marienhaus 醫院集團建立了為期 10 年的技術合作夥伴關係，並可選擇再延長 5 年。 Siemens Healthineas 與 Marienhaus 一起制定了一項數字化戰略，將 18 家醫院相互連接並簡化臨床流程。這可能允許更換和管理德國北萊茵州的約 130 台醫學成像機器。

缺乏熟練的專業人員阻礙了市場增長

但是，就員工而言，有各種就業形式，例如全職和兼職就業，以及跨多個醫院病房和基地的安置。缺乏熟練的專業人員和醫護人員來操作數據管理系統正在限制市場的增長。

COVID-19 影響分析

COVID-19 的出現對全球即時數據管理系統市場產生了重大影響。根據 2022 年 5 月發表在《醫學實驗室觀察員》上的一篇文章，在 COVID-19 大流行之前，POC 測試已經經歷了強勁的增長和高度的接受。由於大流行，人們更加關注以更實惠的成本改善人們的健康。特別是當快速檢測對下游成本和患者結果產生重大影響時，對 POC 檢測的需求變得更加強烈。隨著疫情的發展，POC檢測的價值和快速檢測結果的重要性得到了極大的認可，對高可靠性檢測方法的需求也隨之增加。領先的公司正在提供改進的方法和接口設備來滿足這一需求，從而推動廣泛採用。由於 POC 測試站點可能廣泛分佈在整個醫療園區，因此擁有一個強大的 POC 測試管理系統來捕獲關鍵測試信息和管理法規遵從性至關重要。隨著對 POC 需求的增加，市場對管理系統的需求也在增加。

全球醫療點數據管理系統市場報告將提供對大約 65 多個市場數據表、65 多個數字和 200 多頁（大約）的訪問。

內容

第一章市場研究方法和範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按組件劃分的市場細分
  • 按分銷形式劃分的市場細分
  • 最終用戶的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
    • 驅動程序
      • 技術進步
      • 擴大引入電子病歷 (EHR)
    • 約束因素
      • 缺乏熟練的專業人員
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析
  • 定價分析
  • 未滿足的需求分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按組件

  • 服務
  • 軟件

第 8 章按規定類型

  • 基於網絡
  • 基於雲的
  • 本地

第 9 章，最終用戶

  • 醫院
  • 診所
  • 診斷機構
  • 其他

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 按治療類型劃分的基準

第 12 章公司簡介

  • 西門子醫療解決方案
    • 公司簡介
    • 治療類型組合和描述
    • 主要亮點
    • 財務摘要
  • Abbott Laboratories
  • Danaher Corporation
  • Hoffmann-La Roche Ltd.
  • Orchard Software Corporation
  • Thermo Fisher Scientific Inc.
  • Randox Laboratories Ltd.
  • Hedera Biomedics srl
  • Seaward Electronic Ltd.
  • Esaote SpA

第 13 章全球醫療點數據管理系統市場 -DataM

簡介目錄
Product Code: DMHCIT804

Market Overview

Point Of Care Data Management Systems Market size was valued at US$ YY million in 2021 and is anticipated to reach US$ YY million by 2029, growing at a CAGR of 11.2% during the forecast period (2022-2029).

Point Of Care data management systems accelerate the recording, storing, and viewing of patients' medical records from multiple point-of-care devices at central data management systems. Also, these provide a bidirectional interface to hospitals and laboratory professionals on a single enterprise platform.

Market Dynamics

The point-of-care data management systems market growth is driven by technological advancements in data management systems such as remote monitoring, rising adoption of point-of-care data management systems, increase in the incidence of lifestyle diseases, and rise in healthcare expenditure.

The rising demand for point-of-care data management systems for health records is expected to drive the market growth

The rising adoption of point-of-care data management systems for health records is expected to boost the market over the forecast period. As per the article published in Practical Laboratory Medicine in November 2020, Accreditation and regulatory standards highlight the rising need to integrate POC Testing results into the patient's electric medical records. This promotes accessibility of POCT results, the ability to monitor and trend, prevents unnecessary repeat testing and provides evidence for patient outcomes. As POCT results are used to make clinical decisions, it is important to document results with associated reference intervals, units of measurements, critical values if applicable, date and time of testing, and also be traceable to device serial number, operator identification number, reagent lot number, and quality control (QC) results. POCT results should also be clearly differentiated from other central laboratory results to avoid confusion and trending results from different analytical methodologies. POCT is currently routine in all hospitals and has become the standard for patient care in a variety of other health care settings

In addition, the key players are adopting market strategies. For instance, in March 2020, Siemens Healthineers and Marienhaus Hospital Group collaborated on a ten-year technology partnership, with an option to lengthen for an additional five years. Siemens Healthineers is planning with Marienhaus for a digital strategy to interconnect 18 hospitals to streamline clinical processes. This may provide for the replacement and management of around 130 medical imaging devices in the German states of North Rhin.

The lack of skilled professionals will hamper the growth of the market

However, in the case of employees, cross-appointment to multiple wards and sites and the diverse range of employment types, such as full-time and part-time, increase the challenge of tracking active operators who are trained and have demonstrated competency. The lack of skilled professionals or employees working in healthcare to operate the data management systems limits the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 considerably impacted the global point of care data management systems market. As per an article published in Medical Laboratory Observer in May 2022, before the COVID-19 pandemic, POC testing was already experiencing robust growth and high acceptance. Due to the pandemic, more focus is on improving population health at more affordable costs. The case for POC testing is strong, especially when a quick, rapid turnaround time can profoundly impact downstream costs and patient outcomes. With the pandemic came a significant recognition of the value of POC testing and the importance of rapid test results, along with an increased demand for reliable testing methodologies. Key players respond to this demand with improved methodologies and interfaceable devices, which drive adoption. Because POC testing sites can be widely scattered across a healthcare campus, it is important to have a robust POC testing management system to capture important test information and manage regulatory compliance. The demand for POC increases leads to a demand for management systems in the market.

Segment Analysis

The cloud based segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The cloud based segment accounted for the largest market share in 2021. According to Philips data report, in June 2022, the requirement for data security and regulatory compliance has already motivated healthcare organizations to keep data on-premises. Nowadays, there is a rising awareness that moving to the cloud positively affects the segment in the market.

In fact, 60% of healthcare leaders now cite security as one of the top benefits of the cloud. When healthcare organizations depend on their own data centers, they are responsible for security from end to end, which can become prohibitively complex and time-consuming as IT infrastructures expand over time. Cloud-based services and solutions help to reduce dependency on local hardware to store sensitive data while automated software updates keep systems current.

Healthcare-compliant cloud platforms provide a flexible base for quick development and testing of digital applications. Cross-functional teams working in short and agile cycles are able to put novel digital applications into the hands of physicians or patients right away and then add new or improved features and functionalities as they gather additional user feedback. That means healthcare organizations get to innovate faster and in smaller, more digestible increments.

Geographical Analysis

North America region holds the largest market share of the global point of care data management systems market

North America dominates the market for point of care data management systems and is expected to show a similar trend over the forecast period. It is anticipated to hold a significant market size over the forecast period (2022-2029) owing to advanced healthcare, many key players and the rising population. National Institute of Biomedical Imaging and Bioengineering created the Point-of-Care Technologies Research Network (POCTRN) to drive the development of POC technologies through collaborative efforts that merge scientific and technological capabilities with the clinical need.

In addition, new technologies or products are being refined and improved to deliver easier-to-use devices with incremental improvements in analytical performance. Such advancements in newly launched devices drive the market in the North American region. For instance, in June 2020, DataLink Software (DataLink) highlighted the key advantages of Evoke360 and its Provider Relations Management (PRM) module, enabling providers to transition from fee-for-service to value-based care. Evoke360 serves as a point-of-care solution, aggregating data from disparate sources to accelerate preemptive patient care, closing gaps in care to treat more than the diagnosis results.

Competitive Landscape

The point of care data management systems market is a moderately competitive presence of local and global companies. Some of the key players which are contributing to the growth of the market are Siemens Medical Solutions, Abbott Laboratories, Danaher Corporation, Hoffmann-La Roche Ltd., Orchard Software Corporation, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Hedera Biomedics SRL, Seaward Electronic Ltd., and Esaote SpA among others. The major players are adopting several growth strategies, such as product launches, acquisitions, and collaborations, contributing to the growth of the global point-of-care data management systems market.

For instance,

  • In March 2020, Abbott introduced the molecular point-of-care "ID NOW" COVID-19 test, bringing rapid testing to the front lines. These tests run on Abbott's point-of-care ID NOW platform, a portable instrument, and provide fast results in many healthcare settings, such as physicians' offices, urgent care clinics, and hospital emergency departments. This is the company's second test to receive Emergency Use Authorization by the FDA for COVID-19 detection.

Siemens Medical Solutions

Overview:

Siemens is a German medical device company founded in 1847 and headquartered in Germany. It delivers lab-accurate, actionable, and timely results right away. Clinical management decisions can be made instantly from the ED to the physician's office, resulting in improved clinical outcomes, patient safety, and overall patient satisfaction.

Product Portfolio:

UniPOC Data Management System: It is an open data-management solution that connects and manages the largest ecosystems of point-of-care devices. It provides the POC system with an automated operator validation and recertification process and features active directory integration and compatibility with 64-bit databases and operating systems.

The global point of care data management systems market report would provide access to approximately 65+ market data tables, 65+ figures, and in the range of 200+ (approximate) pages.

Table of Contents

1. Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Component
  • 3.2. Market Snippet By Mode of Delivery
  • 3.3. Market Snippet By End-users
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Technological advancements
      • 4.1.1.2. Rising adoption of Electronic Health Records (EHR)
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of skilled professionals
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis
  • 5.4. Pricing Analysis
  • 5.5. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Component

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component Market Attractiveness Index, By Component
    • 7.1.2. Services*
    • 7.1.3. Introduction
    • 7.1.4. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.1.5. Software

8. By Mode of Delivery

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 8.1.2. Market Attractiveness Index, By Mode of Delivery
  • 8.2. Web-based*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Cloud Based
  • 8.4. On-premise

9. By End-users

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
    • 9.1.2. Market Attractiveness Index, By End-users
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Clinics
  • 9.4. Diagnostics Laboratories
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Mode of Delivery
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Treatment type Benchmarking

12. Company Profiles

  • 12.1. Siemens Medical Solutions*
    • 12.1.1. Company Overview
    • 12.1.2. Treatment type Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Abbott Laboratories
  • 12.3. Danaher Corporation
  • 12.4. Hoffmann-La Roche Ltd.
  • 12.5. Orchard Software Corporation
  • 12.6. Thermo Fisher Scientific Inc.
  • 12.7. Randox Laboratories Ltd.
  • 12.8. Hedera Biomedics srl
  • 12.9. Seaward Electronic Ltd.
  • 12.10. Esaote SpA

LIST NOT EXHAUSTIVE

13. Global Point Of Care Data Management Systems Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us